Beone Medicines (ONC)Officer sold ~$35K

~$35K

Approx. value · 134 sh @ $258.36

Traded

Jun 11, 2025

Filed

Jun 12, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Apr 14, 2025Insider · 1 personInsiders: 13 sales (~$10.1M)
2. May 13, 2025Insider · 1 personInsiders: 4 sales (~$9.3M)
3. Jun 6, 2025Insider · 4 peopleInsiders: 16 sales (~$2.3M)
4. Jun 10, 2025Insider · 1 personInsiders: 5 sales (~$11.0M)
5. Jun 11, 2025 · this disclosureInsiderOfficer sold ~$35K of ONC shares in the open market

What came next

1. Jun 16, 2025Insider · 4 peopleInsiders: 5 sales (~$1.8M)
2. Jun 17, 2025Insider · 3 peopleInsiders: 3 sales (~$651K)
3. Jun 23, 2025Insider · 3 peopleInsiders: 4 sales (~$1.5M)
4. Jun 24, 2025Insider · 1 personInsiders: 4 sales (~$533K)
5. Jul 9, 2025Insider · 1 personInsiders: 4 sales (~$7.0M)
6. Jul 18, 2025InsiderOfficer sold ~$210K of ONC shares in the open market
7. Jul 29, 2025Insider · 1 personInsiders: 3 sales (~$1.2M)
8. Jul 30, 2025Insider · 2 peopleInsiders: 2 sales (~$359K)
9. Aug 1, 2025InsiderCFO sold ~$346K of ONC shares in the open market
10. Aug 13, 2025Insider · 2 peopleInsiders: 8 sales (~$12.4M)
11. Aug 14, 2025Insider · 1 personInsiders: 6 sales (~$10.3M)

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Beone Medicines

For Beone Medicines, OQRO holds 11 insider filings (SEC Form 4 or Form 144) and 6 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ONC page.

Other recent filings by Titus B. Ball, Principal Accounting Officer

• SEC Form 4 at Beone Medicines (ONC)Sep 4, 2025

The full history of Titus B. Ball, Principal Accounting Officer is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Beone Medicines

• SEC Form 4Oct 2, 2026
• SEC Form 4Sep 30, 2026
• SEC Form 4Sep 30, 2026
• SEC Form 4Sep 30, 2026
• SEC Form 4Sep 30, 2026
• SEC Form 4Sep 30, 2026

Everything OQRO holds on this company is on its ONC page.